Pharmaceutical Industry

Drug Development Drug Pricing Market Trends Drug Manufacturing Drug Manufacturers Market Competition Vaccine Development Novo Nordisk Market Dynamics Pricing Strategies

Trump Demands 17 Pharma Firms Cap U.S. Drug Prices at Global Lows Within 60 Days

Companies must agree to link U.S. drug prices to the lowest rates in wealthy nations by Sept. 29 under threat of broad executive enforcement.

HHS Opens Applications for 340B Rebate Model Pilot

Stories older than 24h

US-EU Trade Deal Imposes 15% Tariff on European Drugs

FDA Lifts Hold on Elevidys Shipments to Ambulatory Duchenne Patients

GSK Closes $12 Billion Licensing Pact for Hengrui’s COPD Therapy and 11 Preclinical Assets

Regulators Halt Elevidys Gene Therapy Worldwide After Safety Failures

EU Regulator Recommends AstraZeneca’s Low-Carbon COPD Inhaler

EMA Recommends Restricted Approval for Eli Lilly’s Alzheimer’s Drug Kisunla

Depo-Provera Study Finds 3.5-Times Higher Meningioma Risk as U.S. Suits Top 550

FDA Flags Possible License Revocation for Sarepta’s Elevidys

FDA Names George Tidmarsh Director of Center for Drug Evaluation and Research

Sarepta Defies FDA, Keeps Duchenne Gene Therapy on the Market

FDA Advisers Recommend Against Approval of GSK’s Myeloma Drug Blenrep

Chinese Court Sentences Astellas Pharma Executive to 3½ Years as Japanese Firms Tighten China Protocols

Bristol Myers Squibb and Pfizer to Offer Eliquis at 40% Cash-Price Discount

Newsom Pushes Back on Rogan’s Vaccine Mandate Criticism, Launches Post-Pandemic Review

AstraZeneca’s Baxdrostat Delivers Significant Blood Pressure Reductions in Phase 3 Trial for Resistant Hypertension

FDA Approves Bravecto Quantum Injectable for Year-Long Flea and Tick Prevention

Eight Opioid Manufacturers Settle for $720 Million with Marketing Bans

Hims & Hers Plans Canadian Launch of Generic Semaglutide After Zava Acquisition